Fetal bovine serum and human constitutive androstane receptor: Evidence for activation of the SV23 splice variant by artemisinin, artemether, and arteether in a serum-free cell culture system

Toxicology and Applied Pharmacology

Volumn 277, Issue 2, 2014, Pages 221-230

  Lau, Aik Jiang ^a   Chang, Thomas K H ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Arteether; Artemether; Artemisinin; Constitutive androstane receptor; Di (2 ethylhexyl)phthalate; Fetal bovine serum

Indexed keywords

ARTEETHER; ARTEMETHER; ARTEMISININ; CONSTITUTIVE ANDROSTANE RECEPTOR; DIHYDROARTEMISININ; HUMAN CONSTITUTIVE ANDROSTANE RECEPTOR SV23; LIGAND; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CELL GROWTH; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; FETAL BOVINE SERUM; GENETIC TRANSFECTION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; LIGAND BINDING; PROTEIN FUNCTION; RNA SPLICING; SERUM;

BOVINAE;

ARTEETHER; ARTEMETHER; ARTEMISININ; CONSTITUTIVE ANDROSTANE RECEPTOR; DI-(2-ETHYLHEXYL)PHTHALATE; FETAL BOVINE SERUM;

ARTEMISININS; BIOLOGICAL ASSAY; CELL CULTURE TECHNIQUES; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GENES, REPORTER; HEP G2 CELLS; HUMANS; LIGANDS; PROTEIN ISOFORMS; RECEPTORS, ANDROGEN; REPRODUCIBILITY OF RESULTS; SERUM; TIME FACTORS; TRANSFECTION;

EID: 84899948453     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2014.03.023     Document Type: Article

References (48)

1. Anderson N.L., Polanski M., Pieper R., Gatlin T., Tirumalai R.S., Conrads T.P., Veenstra T.D., Adkins J.N., Pounds J.G., Fagan R., Lobley A. The human plasma proteome: a nonredundant list developed by combination of four separate sources. Mol. Cell. Proteomics 2004, 3:311-326.
2. Anderson L.E., Dring A.M., Hamel L.D., Stoner M.A. Modulation of constitutive androstane receptor (CAR) and pregnane X receptor (PXR) by 6-arylpyrrolo[2,1-d][1,5]benzothiazepine derivatives, ligands of peripheral benzodiazepine receptor (PBR). Toxicol. Lett. 2011, 202:148-154.
3. Arnold K.A., Eichelbaum M., Burk O. Alternative splicing affects the function and tissue-specific expression of the human constitutive androstane receptor. Nucl. Recept. 2004, 2:1-16.
4. Auerbach S.S., Ramsden R., Stoner M.A., Verlinde C., Hassett C., Omiecinski C.J. Alternatively spliced isoforms of the human constitutive androstane receptor. Nucleic Acids Res. 2003, 31:3194-3207.
5. Auerbach S.S., Stoner M.A., Su S., Omiecinski C.J. Retinoid X receptor-α-dependent transactivation by a naturally occurring structural variant of human constitutive androstane receptor (NR1I3). Mol. Pharmacol. 2005, 68:1239-1253.
6. Auerbach S.S., DeKeyser J.G., Stoner M.A., Omiecinski C.J. CAR2 displays unique ligand binding and RXRα heterodimerization characteristics. Drug Metab. Dispos. 2007, 35:428-439.
7. Baes M., Gulick T., Choi H.S., Martinoli M.G., Simha D., Moore D.D. A new orphan member of the nuclear hormone receptor superfamily that interacts with a subset of retinoic acid response elements. Mol. Cell. Biol. 1994, 14:1544-1552.
8. Brunner D., Frank J., Appl H., Schoffl H., Pfaller W., Gstraunthaler G. Serum-free cell culture: the serum-free media interactive online database. ALTEX 2010, 27:53-62.
9. Burk O., Piedade R., Ghebreghiorghis L., Fait J.T., Nussler A.K., Gil J.P., Windshugel B., Schwab M. Differential effects of clinically used derivatives and metabolites of artemisinin in the activation of constitutive androstane receptor isoforms. Br. J. Pharmacol. 2012, 167:666-681.
10. Chai X., Zeng S., Xie W. Nuclear receptors PXR and CAR: implications for drug metabolism regulation, pharmacogenomics and beyond. Expert Opin. Drug Metabol. Toxicol. 2013, 9:253-266.
11. Chen T., Laurenzana E.M., Coslo D.M., Chen F., Omiecinski C.J. Proteasomal interaction as a critical activity modulator of the human constitutive androstane receptor. Biochem. J. 2014, 458:95-107.
12. Choi E.J., Jang Y.J., Cha E.Y., Shin J.G., Lee S.S. Identification and characterization of novel alternative splice variants of human constitutive androstane receptor in liver samples of Koreans and Caucasians. Drug Metab. Dispos. 2013, 41:888-896.
13. DeKeyser J.G., Stagliano M.C., Auerbach S.S., Prabhu K.S., Jones A.D., Omiecinski C.J. Di(2-ethylhexyl) phthalate is a highly potent agonist for the human constitutive androstane receptor splice variant CAR2. Mol. Pharmacol. 2009, 75:1005-1013.
14. DeKeyser J.G., Laurenzana E.M., Peterson E.C., Chen T., Omiecinski C.J. Selective phthalate activation of naturally occurring human constitutive androstane receptor splice variants and the pregnane X receptor. Toxicol. Sci. 2011, 120:381-391.
15. Diamanti-Kandarakis E., Bourguignon J.P., Giudice L.C., Hauser R., Prins G.S., Soto A.M., Zoeller R.T., Gore A.C. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr. Rev. 2009, 30:293-342.
16. Dring A.M., Anderson L.E., Qamar S., Stoner M.A. Rational quantitative structure-activity relationship (RQSAR) screen for PXR and CAR isoform-specific nuclear receptor ligands. Chem. Biol. Interact. 2010, 188:512-525.
17. Faucette S.R., Zhang T.C., Moore R., Sueyoshi T., Omiecinski C.J., LeCluyse E.L., Negishi M., Wang H. Relative activation of human pregnane X receptor versus constitutive androstane receptor defines distinct classes of CYP2B6 and CYP3A4 inducers. J. Pharmacol. Exp. Ther. 2007, 320:72-80.
18. Germain P., Staels B., Dacquet C., Spedding M., Laudet V. Overview of nomenclature of nuclear receptors. Pharmacol. Rev. 2006, 58:685-704.
19. Gstraunthaler G. Alternatives to the use of fetal bovine serum: serum-free cell culture. ALTEX 2003, 20:275-281.
20. Gstraunthaler G., Lindl T., van der Valk J. A plea to reduce or replace fetal bovine serum in cell culture media. Cytotechnology 2013, 65:791-793.
21. Guigal N., Seree E., Bourgarel-Rey V., Barra Y. Induction of CYP1A1 by serum independent of AhR pathway. Biochem. Biophys. Res. Commun. 2000, 267:572-576.
22. Guigal N., Seree E., Nguyen Q.B., Charvet B., Desobry A., Barra Y. Serum induces a transcriptional activation of CYP1A1 gene in HepG2 independently of the AhR pathway. Life Sci. 2001, 68:2141-2150.
23. Gyllenhammar I., Glynn A., Darnerud P.O., Lignell S., van Delft R., Aune M. 4-Nonylphenol and bisphenol A in Swedish food and exposure in Swedish nursing women. Environ. Int. 2012, 43:21-28.
24. Halilbasic E., Baghdasaryan A., Trauner M. Nuclear receptors as drug targets in cholestatic liver diseases. Clin. Liver Dis. 2013, 17:161-189.
25. Hestermann E.V., Stegeman J.J., Hahn M.E. Serum alters the uptake and relative potencies of halogenated aromatic hydrocarbons in cell culture bioassays. Toxicol. Sci. 2000, 53:316-325.
26. Jinno H., Tanaka-Kagawa T., Hanioka N., Ishida S., Saeki M., Soyama A., Itoda M., Nishimura T., Saito Y., Ozawa S., Ando M., Sawada J. Identification of novel alternative splice variants of human constitutive androstane receptor and characterization of their expression in the liver. Mol. Pharmacol. 2004, 65:496-502.
27. Kohle C., Bock K.W. Coordinate regulation of human drug-metabolizing enzymes, and conjugate transporters by the Ah receptor, pregnane X receptor and constitutive androstane receptor. Biochem. Pharmacol. 2009, 77:689-699.
28. Lamba J.K. Pharmacogenetics of the constitutive androstane receptor. Pharmacogenomics 2008, 9:71-83.
29. Lamba J.K., Lamba V., Yasuda K., Lin Y.S., Assem M., Thompson E., Strom S., Schuetz E. Expression of constitutive androstane receptor splice variants in human tissues and their functional consequences. J. Pharmacol. Exp. Ther. 2004, 311:811-821.
30. Lau A.J., Chang T.K.H. Indirect activation of the SV23 and SV24 splice variants of human constitutive androstane receptor: analysis with 3-hydroxyflavone and its analogues. Br. J. Pharmacol. 2013, 170:403-414.
31. Lau A.J., Yang G., Rajaraman G., Baucom C.C., Chang T.K.H. Human pregnane X receptor agonism by Ginkgo biloba extract: assessment of the role of individual ginkgolides. J. Pharmacol. Exp. Ther. 2010, 335:771-780.
32. Lau A.J., Yang G., Chang T.K.H. Isoform-selective activation of human constitutive androstane receptor by Ginkgo biloba extract: functional analysis of the SV23, SV24, and SV25 splice variants. J. Pharmacol. Exp. Ther. 2011, 339:704-715.
33. Li L., Hassan H.E., Tolson A.H., Ferguson S.S., Eddington N.D., Wang H. Differential activation of pregnane X receptor and constitutive androstane receptor by buprenorphine in primary human hepatocytes and HepG2 cells. J. Pharmacol. Exp. Ther. 2010, 335:562-571.
34. Maglich J.M., Parks D.J., Moore L.B., Collins J.L., Goodwin B., Billin A.N., Stoltz C.A., Kliewer S.A., Lambert M.H., Willson T.M., Moore J.T. Identification of a novel human constitutive androstane receptor (CAR) agonist and its use in the identification of CAR target genes. J. Biol. Chem. 2003, 278:17277-17283.
35. Moore L.B., Parks D.J., Jones S.A., Bledsoe R.K., Consler T.G., Stimmel J.B., Goodwin B., Liddle C., Blanchard S.G., Willson T.M., Collins J.L., Kliewer S.A. Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J. Biol. Chem. 2000, 275:15122-15127.
36. Mutoh S., Sobhany M., Moore R., Perera L., Pedersen L., Sueyoshi T., Negishi M. Phenobarbital indirectly activates the constitutive active androstane receptor (CAR) by inhibition of epidermal growth factor receptor signaling. Sci. Signal. 2013, 6:ra31.
37. Oh D.H., Bang J.S., Choi H.M., Yang H.I., Yoo M.C., Kim K.S. Fetal bovine serum requirement for pyrrolidine dithiocarbamate-induced apoptotic cell death of MCF-7 breast tumor cells. Eur. J. Pharmacol. 2010, 649:135-139.
38. Omiecinski C.J., Coslo D.M., Chen T., Laurenzana E.M., Peffer R.C. Multi-species analyses of direct activators of the constitutive androstane receptor. Toxicol. Sci. 2011, 123:550-562.
39. Psychogios N., Hau D.D., Peng J., Guo A.C., Mandal R., Bouatra S., Sinelnikov I., Krishnamurthy R., Eisner R., Gautam B., Young N., Xia J., Knox C., Dong E., Huang P., Hollander Z., Pedersen T.L., Smith S.R., Bamforth F., Greiner R., McManus B., Newman J.W., Goodfriend T., Wishart D.S. The human serum metabolome. PLoS One 2011, 6:e16957.
40. Raucy J., Warfe L., Yueh M.F., Allen S.W. A cell-based reporter gene assay for determining induction of CYP3A4 in a high-volume system. J. Pharmacol. Exp. Ther. 2002, 303:412-423.
41. Ross J., Plummer S.M., Rode A., Scheer N., Bower C.C., Vogel O., Henderson C.J., Wolf C.R., Elcombe C.R. Human constitutive androstane receptor (CAR) and pregnane X receptor (PXR) support the hypertrophic but not the hyperplastic response to the murine nongenotoxic hepatocarcinogens phenobarbital and chlordane in vivo. Toxicol. Sci. 2010, 116:452-466.
42. Savkur R.S., Wu Y., Bramlett K.S., Wang M., Yao S., Perkins D., Totten M., Searfoss G., Ryan T.P., Su E.W., Burris T.P. Alternative splicing within the ligand binding domain of the human constitutive androstane receptor. Mol. Genet. Metab. 2003, 80:216-226.
43. Sprague B.L., Trentham-Dietz A., Hedman C.J., Wang J., Hemming J.D., Hampton J.M., Buist D.S., Aiello Bowles E.J., Sisney G.S., Burnside E.S. Circulating serum xenoestrogens and mammographic breast density. Breast Cancer Res. 2013, 15:R45.
44. Sueyoshi T., Kawamoto T., Zelko I., Honkakoski P., Negishi M. The repressed nuclear receptor CAR responds to phenobarbital in activating the human CYP2B6 gene. J. Biol. Chem. 1999, 274:6043-6046.
45. Swanson H.I., Wada T., Xie W., Renga B., Zampella A., Distrutti E., Fiorucci S., Kong B., Thomas A.M., Guo G.L., Narayanan R., Yepuru M., Dalton J.T., Chiang J.Y. Role of nuclear receptors in lipid dysfunction and obesity-related diseases. Drug Metab. Dispos. 2013, 41:1-11.
46. van der Valk J., Mellor D., Brands R., Fischer R., Gruber F., Gstraunthaler G., Hellebrekers L., Hyllner J., Jonker F.H., Prieto P., Thalen M., Baumans V. The humane collection of fetal bovine serum and possibilities for serum-free cell and tissue culture. Toxicol In Vitro 2004, 18:1-12.
47. van der Valk J., Brunner D., De Smet K., Fex Svenningsen A., Honegger P., Knudsen L.E., Lindl T., Noraberg J., Price A., Scarino M.L., Gstraunthaler G. Optimization of chemically defined cell culture media-replacing fetal bovine serum in mammalian in vitro methods. Toxicol. in Vitro 2010, 24:1053-1063.
48. Villard P.H., Barlesi F., Armand M., Dao T.M., Pascussi J.M., Fouchier F., Champion S., Dufour C., Ginies C., Khalil A., Amiot M.J., Barra Y., Seree E. CYP1A1 induction in the colon by serum: involvement of the PPARα pathway and evidence for a new specific human PPREα site. PLoS One 2011, 6:e14629.